NCT04035447Completed
Symptom Management for YA Cancer Survivors
Improving Symptom Management for Survivors of Young Adult Cancer
Source: ClinicalTrials.gov · Last updated 29 Jun 2025
Brief summary (registry, in English)
Symptom interference is common for survivors of young adult cancer (aged 18-39 at diagnosis) and impacts their abilities to achieve normative life goals (e.g., education, careers, independence, romantic/social relationships) as well as adhere to recommended follow-up care. Assistance with symptom management has been rated by young adult survivors as an important and unmet healthcare need; however, skill-based symptom management interventions have typically been tested among older cancer survivors and have not targeted the unique developmental needs of those diagnosed as young adults. The proposed research advances the health and wellbeing of young adult cancer survivors by creating a developmentally appropriate hybrid in-person/mHealth behavioral symptom management intervention which addresses variables (i.e., symptoms and symptom interference) consistently linked to significant social, economic, and health burden.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 65 (actual)
- First submitted
- 24 Jul 2019
- Start date
- 22 Jan 2020
- Primary completion date
- 15 Jun 2024
- Lead sponsor
- Duke University
- Diseases
- Melanoma
- NCT number
- NCT04035447
What you commit to
- Study type: Interventional
- Participants enrolled: 65
- From 22 Jan 2020 to the primary completion date, 15 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Completed curative treatment involving multimodal therapy within the last five years
- receiving care at the Duke Cancer Institute
- completed curative treatment involving multimodal therapy within the last 2 years
Other illness
- Major mental illness, i.e., schizophrenia
- Untreated or uncontrolled mental illness, i.e., bipolar
- Residence greater than 100 miles from the research site
- Medical Providers Participating in Intervention Development Interviews Eligibility criteria
- o Provide care to young adult cancer survivors at the Duke Cancer Institute
- Young Adult Cancer Survivor User Testers
- Eligibility Criteria
- Diagnosed with hematologic, breast, gastrointestinal cancers, or endocrine cancers, melanoma, or germ cell tumors
- Diagnosed with cancer as a young adult
- Under the care of a medical provider at the Duke Cancer Institute
- Major mental illness, i.e., schizophrenia
- Untreated or uncontrolled mental illness, i.e., bipolar
- diagnosis of hematologic, breast, endocrine or gastrointestinal cancer, melanoma, or germ cell tumor
- major mental illness (i.e., schizophrenia)
- untreated or uncontrolled mental illness (i.e., bipolar disorder)
Age
- diagnosed with cancer as a YA (aged 18-39)
Other
- Nonambulatory
- Able to speak and read English
- Able to give informed consent
- Nonambulatory
- Residence great than 100 miles from the research site
- RCT Participants
- Eligibility Criteria:
- able to speak/read English; and able to give informed consent.
- non-ambulatory
Criteria the registry did not label
- Young Adult Cancer Survivors Participating in Intervention Development Interviews
- Eligibility Criteria
- Diagnosed with hematologic, breast, gastrointestinal, or endocrine cancers, melanoma, or germ cell tumors
- Diagnosed with cancer as a young adult
- Under the care of a medical provider at the Duke Cancer Institute
- Completed curative treatment involving multimodal therapy within the last five years
- Able to speak and read English
- Able to give informed consent
Age in the registry: 18 years to 39 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Duke Cancer Institute Coordinator of this site? Confirm its status | Durham | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.